1-20 of 40
Celeste M. Bello
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Real-World Safety and Tolerability of Pirtobrutinib Among Patients with B Cell Lymphomas; A Single Center Experience

Mohammad Ammad Ud Din, Katherine Tobon, Julio C. Chavez, Lisa Nodzon, Hayder Saeed, Sameh Gaballa, Ning Dong, Leidy Lismeris Isenalumhe, Celeste M. Bello, Ariel Grajales-Cruz, Kenneth H. Shain, Lubomir Sokol, Bijal D Shah, Javier Pinilla-Ibarz
Journal: Blood
Blood (2024) 144 (Supplement 1): 6778.
https://doi.org/10.1182/blood-2024-208769
Published: 2024
Journal Articles

Clinical Characteristics and Outcomes of Patients with MYD88 Positive Waldenström Macroglobulinemia: A Single Center Retrospective Analysis

Shrinjaya B Thapa, David Kaldas, Jose Laborde, Shrikar Modukuri, Filip Ionescu, Brandon Blue, Julio C. Chavez, Melissa Alsina, Celeste M. Bello, Javier Pinilla-Ibarz, Kenneth H. Shain, Rachid C. Baz, Ariel Grajales-Cruz
Journal: Blood
Blood (2024) 144 (Supplement 1): 3021.
https://doi.org/10.1182/blood-2024-208701
Published: 2024
Journal Articles

A Phase I Study of Duvelisib in Combination with Oral Azacitidine (BMS-986345) in Mature T Cell Lymphoma

Hayder Saeed, Melanie Mediavilla Varela, Eva Sahakian, Mahrukh Naqvi, Qiangxing Mo, Ling Zhang, Rikesh Makanji, Yumeng Zhang, Ning Dong, Leidy Lismeris Isenalumhe, Sameh Gaballa, Julio C. Chavez, Bijal D Shah, Celeste M. Bello, Lubomir Sokol, Javier Pinilla-Ibarz
Journal: Blood
Blood (2024) 144 (Supplement 1): 3065.
https://doi.org/10.1182/blood-2024-205173
Published: 2024
Journal Articles

A Retrospective Study on Outcomes of Secondary CNS Lymphoma: Pattern of Relapse, Prognostic Factors, and Role of Consolidation Therapy

Aditi Saha, Junmin Whiting, Mohammad Ammad-ud-din, Cole Powell, Kristen Flores, Felix Sanjay, Humaira Sarfraz, Khushali Jhaveri, Michael V. Jaglal, Katherine Tobon, Hayder Saeed, Celeste M. Bello, Bijal D. Shah, Leidy Lismeris Isenalumhe, Javier Pinilla-Ibarz, Lubomir Sokol, Julio C Chavez, Ning Dong
Journal: Blood
Blood (2023) 142 (Supplement 1): 1750.
https://doi.org/10.1182/blood-2023-188211
Published: 2023
Journal Articles

B-Cell Maturation Antigen (BCMA) Expression and Clinical Features of Plasmablastic Lymphoma (PBL)

Ning Dong, Hailing Zhang, Jinming Song, Jamila Mammadova, Bijal D. Shah, Hayder Saeed, Ariel F. Grajales-Cruz, Leidy Lismeris Isenalumhe, Sameh Gaballa, Celeste M. Bello, Lubomir Sokol, Javier Pinilla-Ibarz, Julio C Chavez
Journal: Blood
Blood (2023) 142 (Supplement 1): 3138.
https://doi.org/10.1182/blood-2023-184779
Published: 2023
Journal Articles

Clinical Characteristics, Treatment Strategies, and Outcomes for CLL Patients with BTK Mutation; A Single Center Study

Mohammad Ammad Ud Din, Todd C Knepper, Julio C. Chavez, Lisa Nodzon, Hayder Saeed, Sameh Gaballa, Lubomir Sokol, Ning Dong, Leidy Lismeris Isenalumhe, Celeste M. Bello, Bijal D. Shah, Javier Pinilla-Ibarz
Journal: Blood
Blood (2023) 142 (Supplement 1): 1911.
https://doi.org/10.1182/blood-2023-179658
Published: 2023
Journal Articles

Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma

Clinical Trials & Observations
Jeremy S. Abramson, Jon E. Arnason, Ann S. LaCasce, Robert Redd, Jeffrey A. Barnes, Lubomir Sokol, Robin Joyce, David Avigan, Donna Neuberg, Ronald W. Takvorian, Ephraim P. Hochberg, Celeste M. Bello
Journal: Blood
Blood (2019) 134 (7): 606–613.
https://doi.org/10.1182/blood.2019001272
Published: 2019
Includes: Supplemental data
Journal Articles

Long-Term Follow up of Front-Line Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide (HiLO trial) for Treatment-Naïve Chronic Lymphocytic Leukemia

Ariel Felipe Grajales-Cruz, MD, Julio C. Chavez, MD, Elyce P. Turba, MSN, RN, Lisa Nodzon, PhD ARNP, AOCNP, Francisco Perez Leal, MD, Jose Sandoval-Sus, MD, Rami S. Komrokji, MD, Frederick L. Locke, MD, Mohamed A Kharfan-Dabaja, MD, Bijal D. Shah, MD, Lubomir Sokol, MD PhD, Celeste M. Bello, MD, Javier Pinilla Ibarz, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3150.
https://doi.org/10.1182/blood-2018-99-111564
Published: 2018
Journal Articles

A Phase II Study of Brentuximab Vedotin Plus Adriamycin and Dacarbazine without Radiation in Non-Bulky Limited Stage Classical Hodgkin Lymphoma

Jeremy S. Abramson, MD MMSc, Robert A. Redd, MS, Jeffrey A. Barnes, MD PhD, Elizabeth Bengtson, MD, Ronald W. Takvorian, MD, Lubomir Sokol, MD PhD, Frederick Lansigan, MD, Philippe Armand, MD PhD, Bijal D. Shah, MD, Eric D Jacobsen, MD, Donna S Neuberg, ScD, Ann S. LaCasce, MD MSc, Celeste M. Bello, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1654.
https://doi.org/10.1182/blood-2018-99-115173
Published: 2018
Journal Articles

Impact of Serum Albumin in the Prognosis of Myc-Positive Aggressive B-Cell Lymphomas: Potential for a Novel Prognostic Score

Chetasi Talati, MD, Andrew Kuykendall, MD, Jori Kaplan, MD, Jose D Sandoval-Sus, MD, Samir Dalia, MD, Bijal D. Shah, MD, Celeste M. Bello, MD, Farhad Khimani, MD, Paul A. Chervenick, MD, Ernesto Ayala, MD, Frederick L. Locke, MD, Mohamed A Kharfan-Dabaja, MD, Eduardo M. Sotomayor, MD, Lubomir Sokol, Julio C. Chavez, MD
Journal: Blood
Blood (2016) 128 (22): 1870.
https://doi.org/10.1182/blood.V128.22.1870.1870
Published: 2016
Journal Articles

Sequential Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide Is a Safe and Effective Regimen for the Treatment of Previously Treated and Untreated CLL/SLL: The Hilo Trial

Javier Pinilla-Ibarz, Julio C Chavez, MD, Elyce Turba, RN, MSN, OCN, Lisa Nodzon, PhDANP, Jennifer rock-Klotz, BA, Samir Dalia, MD, Rami S. Komrokji, MD, Frederick L. Locke, MD, Mohamed A Kharfan-Dabaja, MD, Celeste M. Bello, MD
Journal: Blood
Blood (2015) 126 (23): 2941.
https://doi.org/10.1182/blood.V126.23.2941.2941
Published: 2015
Journal Articles

Outcomes of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia after Ibrutinib Discontinuation Outside Clinical Trials: A Single Institution Experience

Jose D Sandoval-Sus, MD, Julio C Chavez, MD, Samir Dalia, MD, Celeste M. Bello, MD, Bijal D. Shah, MD, Viet Q. Ho, PharmD, RPh, BCOP, Lisa Nodzon, PhDANP, Mohamed A. Kharfan-Dabaja, MD, Eduardo M. Sotomayor, MD, Lubomir Sokol, MD PhD, Javier Pinilla-Ibarz
Journal: Blood
Blood (2015) 126 (23): 2945.
https://doi.org/10.1182/blood.V126.23.2945.2945
Published: 2015
Journal Articles

Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression

Clinical Trials & Observations
Eric D. Jacobsen, Jeff P. Sharman, Yasuhiro Oki, Ranjana H. Advani, Jane N. Winter, Celeste M. Bello, Gary Spitzer, Maria Corinna Palanca-Wessels, Dana A. Kennedy, Pamela Levine, Jing Yang, Nancy L. Bartlett
Journal: Blood
Blood (2015) 125 (9): 1394–1402.
https://doi.org/10.1182/blood-2014-09-598763
Published: 2015
Includes: Supplemental data
Journal Articles

Increased Treatment Intensity Is Not Associated with a Survival Benefit in Patients with Low and Intermediate Risk Mantle Cell Lymphoma, a Retrospective Analysis

Patrick T. Griffin, MD, Julio C Chavez, MD, Celeste M. Bello, MD, Lubomir Sokol, MD PhD, Paul A. Chervenick, MD, Ernesto Ayala, MD, Jianguo Tao, MD PhD, Eduardo M. Sotomayor, MD, Bijal D. Shah, MD
Journal: Blood
Blood (2014) 124 (21): 4424.
https://doi.org/10.1182/blood.V124.21.4424.4424
Published: 2014
Journal Articles

Multivariate Survival Analysis of Transformed Lymphoma in the Chemoimmunotherapy Era: Impact of the NCCN International Prognostic Index

Patrick T. Griffin, MD, Samir Dalia, MD, Bijal D. Shah, MD, Lubomir Sokol, MD PhD, Celeste M. Bello, MD, Paul A. Chervenick, MD, Eduardo M. Sotomayor, MD, Julio C Chavez, MD
Journal: Blood
Blood (2014) 124 (21): 2981.
https://doi.org/10.1182/blood.V124.21.2981.2981
Published: 2014
Journal Articles

Concurrent Epstein Barr Virus Viremia and Hodgkin Lymphoma In Two Patients With Chronic Lymphocytic Leukemia

Samir Dalia, MD, Jason B. Brayer, MD, PhD, Julio C Chavez, MD, Celeste M. Bello, MD, Bijal D. Shah, MD, Pedro Horna, M.D., Hailing Zhang, MD, Lubomir Sokol, MD, Ph.D, Eduardo M. Sotomayor, MD, Javier Pinilla-Ibarz, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5290.
https://doi.org/10.1182/blood.V122.21.5290.5290
Published: 2013
Journal Articles

A New Prognostic Index In Diffuse Large B-Cell Lymphoma Using Serum Albumin: A Pilot Study Evaluating The Albumin Adjusted-International Prognostic Index (A-IPI)

Samir Dalia, MD, Julio C Chavez, MD, Celeste M. Bello, MD, Paul A. Chervenick, MD, Bryan J Little, MPH, Najla H Al Ali, Lubomir Sokol, MD, Ph.D, Eduardo M. Sotomayor, MD, Ji-Hyun Lee, PhD, Kate Fisher, MA, Zachary Thompson, PhD, Bong-jin Choi, MA, Bijal D. Shah, MD
Journal: Blood
Blood (2013) 122 (21): 4267.
https://doi.org/10.1182/blood.V122.21.4267.4267
Published: 2013
Journal Articles

A Retrospective Evaluation Of Insurance Status As It Relates To Outcomes In Diffuse Large B-Cell Lymphoma

Bryan J Little, MPH, Julio C Chavez, MD, Celeste M. Bello, MD, Paul Chervenick, MD, Lubomir Sokol, MD, Ph.D, Eduardo M. Sotomayor, MD, Bijal D. Shah, MD
Journal: Blood
Blood (2013) 122 (21): 1702.
https://doi.org/10.1182/blood.V122.21.1702.1702
Published: 2013
Journal Articles

Clinical Activity Of Idelalisib (GS-1101), a Selective Inhibitor Of PI3Kδ, In Phase 1 and 2 Trials In Chronic Lymphocytic Leukemia (CLL): Effect Of Del(17p)/TP53 Mutation, Del(11q), IGHV Mutation, and NOTCH1 Mutation

Steven E. Coutre, MD, John P. Leonard, MD, Jacqueline C. Barrientos, MD, Sven De Vos, MD, PhD, Ian Flinn, MD, PhD, Richard R. Furman, MD, Jennifer R Brown, MD, PhD, Nina Wagner-Johnston, MD, Don M. Benson, Jr., MD, PhD, Marshall T. Schreeder, MD, Jeff P. Sharman, MD, Thomas Boyd, MD, Stephen Spurgeon, MD, Andrew D. Zelenetz, MD, PhD, Nicole Lamanna, MD, Thomas J. Kipps, MD, PhD, Brad S. Kahl, MD, Celeste M. Bello, MD, Jan A. Burger, MD, PhD, Kanti R. Rai, MD, Roger Dansey, MD, Yeonhee Kim, PhD, Leanne M. Holes, Mirella Lazarov, PhD, Ronald L. Dubowy, MD, Susan M. O'Brien, MD
Journal: Blood
Blood (2013) 122 (21): 1632.
https://doi.org/10.1182/blood.V122.21.1632.1632
Published: 2013
Journal Articles

What Is The Optimal Dose Of Methotrexate In Primary Central Nervous System Lymphoma Treatment Regimens?

Samir Dalia, MD, Samantha L Price, PharmD, Peter Forsyth, MD, Celeste M. Bello, MD, Bijal D. Shah, MD, Lubomir Sokol, MD, Ph.D, Eduardo M. Sotomayor, MD, Michael V. Jaglal, MD
Journal: Blood
Blood (2013) 122 (21): 3040.
https://doi.org/10.1182/blood.V122.21.3040.3040
Published: 2013